MTN 015

Principal Investigator(s):Sharon A. Riddler
Objective:A long-term observational study that seeks to understand the nature of HIV progression and treatment response among women who acquired HIV while taking part in an MTN parent study of ARV-based prevention products. Results: MTN-015 was implemented initially at six African sites and enrolled 100/139 (72%) of eligible women who seroconverted in HIV Prevention Trials Network protocol 035 (HPTN 035, conducted by the MTN). The median time from seroconversion in HPTN 035 to enrollment in MTN-015 was 18 months.     Last updated May 10, 2021
Start Date
End Date
August 25, 2008
June 30, 2019
Age range: ↔ any
Population:People Living with HIV